JAPANESE JOURNAL OF LEPROSY
Online ISSN : 1884-314X
Print ISSN : 1342-3681
ISSN-L : 1342-3681
Volume 71, Issue 3
Displaying 1-10 of 10 articles from this issue
  • Yukiko Fukunishi
    2002 Volume 71 Issue 3 Pages 179-186
    Published: 2002
    Released on J-STAGE: November 30, 2007
    JOURNAL FREE ACCESS
    “AFIP classification” by light microscopy was of help to analize the skin lesions of Buruli ulcer, in which the histopathology were classified into 6 stages i.e. active, healing, active but healing, consistent with active and chronic stages.
    In this paper, skin lesions biopsied from 41 cases of Buruli ulcer were observed by light microscopy. Those were sent from Benin in west Africa at 1997, and under the control of Armed Forces Institute of Pathology(AFIP) in Washington DC, USA.
    Each age, sex, biopsy lesions and histopathological stage and corresponding characteristic histopathological findings of 41 cases except that of chronic stage were analyzed and herewith reported by this paper.
    Download PDF (4137K)
  • Yo Yuasa
    2002 Volume 71 Issue 3 Pages 187-193
    Published: 2002
    Released on J-STAGE: November 30, 2007
    JOURNAL FREE ACCESS
    Convinced with an effectiveness of MDT for curing leprosy as an infections disease since 1982, WHO has presented to the 44th World Health Assembly (WHA) in May 1991, a resolution on “The Elimination of Leprosy, as a public health problem, by year 2000”, with a numerical target of achieving a prevalence of leprosy of one case per 10, 000 population, and it was unanimously adopted. Since then all the leprosy endemic countries of the world has expanded their MDT programmes to cover the whole country, aided by free availability of MDT drugs through WHO since 1995, and succeeded in reaching the target on global basis at the end of 2000, with reduction of leprosy endemic countries down to 12 from nearly 100. At the WHA of 2000, WHO has put a new resolution to achieve the same target, at a national level, by 2005, and the programme is progressing reasonably well in terms of reducing the number of cases registered.
    However this single minded endeavor of WHO is causing some difficulties, in terms of more comprehensive care of patients, specially in POD and rehabilitation activities. In addition, WHO's public announcements give a strong impression that by the end of 2005 all leprosy problems will be solved with nothing more to do beyond that time. In this presentation, what has been achieved so far, and what needs to be done will be presented briefly. Then various issues facing us currently will be discussed in relation to a realistically perceived final goal, which the speaker defines as “A World without Leprosy related Problems, both medical and social”, rather than more commonly accepted “Eradication of Leprosy” or “A World without Leprosy”, and explains the reasons.
    Finally leprosy within the context of human history is discussed rather briefly, pointing out that leprosy patients, throughout history and almost everywhere in the world, suffered a worst case of human rights violation to any minority groups, because they have been conceived as a group of people totally alien to the society. The speakers believe that true understanding of the basic nature of leprosy problems and efforts to solve them will contribute to improved human relationship in general in the world, where any minorities need not to suffer any more, and able to coexist with the surrounding majorities.
    Download PDF (3983K)
  • [in Japanese]
    2002 Volume 71 Issue 3 Pages 195-196
    Published: 2002
    Released on J-STAGE: November 30, 2007
    JOURNAL FREE ACCESS
    Download PDF (593K)
  • Masanori Matsuoka
    2002 Volume 71 Issue 3 Pages 197-200
    Published: 2002
    Released on J-STAGE: November 30, 2007
    JOURNAL FREE ACCESS
    The frame work of international cooperative work was discussed toward the solution current problems of the leprosy on the view point of researcher involved in fundamental study. Prevention of further reduction of research activity was stressed.
    Download PDF (1873K)
  • Kazuo Hikita, Hiroko Baba, Chiyoko Hashiomto, Yuataka Ishida, Yoshiko ...
    2002 Volume 71 Issue 3 Pages 201-210
    Published: 2002
    Released on J-STAGE: November 30, 2007
    JOURNAL FREE ACCESS
    Many tropical and subtropical communicable diseases are prevalent in Myanmar still now. Leprosy also is not completely controlled in spite of making exertions by the Government of Myanmar and more than 10, 000 new leprosy patients were detected every year. In response to the pressure of World Health Organization ( WHO ), the government of Myanmar declared to eliminate this disease by the end of 2003, and all vertical staff concerned with leprosy control program concentrate to reach the goal of elimination ( Prevalence rate : less than 1.0 per 10, 000 population ).
    Leprosy Control and Basic Health Services Project will be carried out in the project sites for 5 years, that is, from April, 2000 to March, 2001. Project purpose that was mentioned in the PDM were to support the leprosy control programme in Myanmar through the strengthening of Basic Health Service system by conducting training activities and other diseases' control programmes such as TB and Measles, by fully utilizing the above training opportunities. The Project started to conduct the main activities from 2001 as follows,
    (1) BHS training (2) Training of microscopic diagnosis (3) Sewing training as one of social rehabilitations (4) Training of reconstructive surgery (5) Survey on disabilities of leprosy patients, etc.
    Download PDF (4468K)
  • CHAIWUT BUNDIT, PRASERT SAMPOONACHOT, KRISADA MAHOTARN
    2002 Volume 71 Issue 3 Pages 211-213
    Published: 2002
    Released on J-STAGE: November 30, 2007
    JOURNAL FREE ACCESS
    In the year 2002, leprosy situation in Thailand has been steadily progress. However, the prevalence rate and percentage of leprosy patients are still quite high in the North-Eastern part of Thailand. Therefore, we have focused our plan of action 2001-2 on “The strengthening of Leprosy Elimination and Prevention of Disability in the North-Eastern Region.” The objective of which is to improve and sustain the ability of leprosy related staff to conduct activities such as case finding, complication diagnosis, treatment of disabilities, rehabilitation, supervision and evaluation. The International Medical Co-operation for Leprosy in 2001, we received funds from Netherland Leprosy Relief Association (NLR) for 9 programmes concerning training of leprosy for health officers and assessment of the quality of life for leprosy affected persons living in northeastern colonies. There are 3 training courses of leprosy for new medical doctors, lab technicians from community and provincial hospitals and 2 workshops on Rehabilitation and Development of Leprosy Affected Persons “Quality of Life” under the Germany Leprosy Relief Association (GLRA) support. From Japan we received funding from Sasakawa Memorial Health Foundation (SMHF) for 4 projects in immunological studies since 1997 and 2 projects concerning dental services for Leprosy patients in the north and northeast regions from Umemoto Memorial Dental Service Group (UMDSG). The medical co-operation between Japan and Thailand should increase in many aspects especially. for new chemotherapy, immunotherapy and vaccine study in Leprosy. The future vision of Leprosy, we plan to set up the International Center of Leprosy for medical officers, technicians, etc. for the South-East Asian Countries. You are welcome to join and work together with us.
    Download PDF (1340K)
  • Kentaro Hatano
    2002 Volume 71 Issue 3 Pages 215-221
    Published: 2002
    Released on J-STAGE: November 30, 2007
    JOURNAL FREE ACCESS
    Developing countries have their own unique characteristics, histories, and situation. There are great differences from country to country. From the experiences worked in both Bangladesh and Myanmar which share their border, some similarities and dissimilarities among these two greatly different countries are discussed. Considering this, common problems on leprosy in the developing countries are analyzed.
    The needs of developing countries in the field of leprosy are studied, and the possible way of corroboration for us, Japanese leprosy workers, are suggested.
    Download PDF (3241K)
  • Norihisa ISHII, Akiko OBARA, Motoaki OZAKI, Kimiko KUMANO, Yasuyuki SU ...
    2002 Volume 71 Issue 3 Pages 223-233
    Published: 2002
    Released on J-STAGE: November 30, 2007
    JOURNAL FREE ACCESS
    We analyzed the medical and social problems of newly registered leprosy patients in the past 8 years from 1993 to 2000 in a low endemic country, Japan. There were 56 registered Japanese patients (males, 32; females, 24), and 76 registered foreign patients (males, 56; females, 20). The number of Japanese patients in each year was between 5 and 9, and 2/3of them were from Okinawa Prefecture, located in subtropical zone. But the number of foreign patients in each year was between 5 and 18, and 2/5 of them were from Brazil. The number of foreign patients was greater than that of Japanese patients. Male/female ratio has decreased among the Japanese.
    Download PDF (4645K)
  • Masako Namisato, Masamichi Goto, Masaichi Gidoh, Atsushi Hosokawa, Yas ...
    2002 Volume 71 Issue 3 Pages 235-238
    Published: 2002
    Released on J-STAGE: November 30, 2007
    JOURNAL FREE ACCESS
    In Japan, a cautious definition of clinical cure of leprosy has been used since 1988. This report presents a new definition of clinical cure for leprosy patients after multi-drug treatment is completed. When the patients complete the standard treatment published in 2000, they are defined as “clinically cured”. The doctor in charge should inform the patient of the cure of the disease clearly. On the release from the treatment, it is important to explain necessary cares for protection against injuries and prevention from deformities. The patient should be careful about signs of relapse and reactions.
    Download PDF (1735K)
  • [in Japanese]
    2002 Volume 71 Issue 3 Pages 239-244
    Published: 2002
    Released on J-STAGE: November 30, 2007
    JOURNAL FREE ACCESS
    Download PDF (3839K)
feedback
Top